OSCR Kelas A Oscar Health, Inc. Class A Common Stock
NYSE · Insurance · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 7, 2026OSCR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
OSCR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Tentang Oscar Health, Inc. Class A Common Stock Tinjauan perusahaan dari Wikipedia
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
History
2012–2015
According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.
2016
Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".
In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."
2017
On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.
On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.
A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.
While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.
2020–present
In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."
As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."
Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.
Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.
Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.
In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.
Marketing and brand
Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".
In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.
In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.
Finances
Funding
Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.
During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.
During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.
In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.
During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.
In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.
Revenue
In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.
Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."
By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.
In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.
In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.
In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.
In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.
Headquarters and offices
Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | OSCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 21.3rata-rata 5T ≈23.0 | ≈23.0 | 15.4 | Terlalu mahal |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | OSCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | 4.1%rata-rata 5T ≈-9.1% | ≈-9.1% | 10.1% | Lemah | |
| Margin EBITDA (TTM) | 4.3%rata-rata 5T ≈-8.6% | ≈-8.6% | 8.2% | Sejajar | |
| Margin Sebelum Pajak (TTM) | 3.9%rata-rata 5T ≈-9.7% | ≈-9.7% | 17.3% | Lemah | |
| Margin Laba Bersih (TTM) | 3.6%rata-rata 5T ≈-9.8% | ≈-9.8% | 10.3% | Lemah | |
| ROA (TTM) | 6.3%rata-rata 5T ≈-8.6% | ≈-8.6% | 0.54% | Lemah | |
| ROE (TTM) | 34.3%rata-rata 5T ≈-27.6% | ≈-27.6% | 12.2% | Lemah | |
| ROIC | -28.5%rata-rata 5T ≈-21.5% | ≈-21.5% | 15.6% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | OSCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.2rata-rata 5T ≈0.3 | ≈0.3 | 0.0 | Utang tinggi | |
| Rasio Lancar (MRQ) | 1.1rata-rata 5T ≈1.1 | ≈1.1 | · | · | |
| Quick Ratio (Rasio Cepat) | 0.6rata-rata 5T ≈0.6 | ≈0.6 | · | · | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 0.2rata-rata 5T ≈0.3 | ≈0.3 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | OSCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 27.5%rata-rata 5T ≈109.0% | ≈109.0% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 43.5%rata-rata 5T ≈82.5% | ≈82.5% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 90.8% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | OSCR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 2.1rata-rata 5T ≈1.6 | ≈1.6 | 0.1 | Tingkat teratas | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$5.1M | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 6, 2026 | $1.10 | $0.39 | 179.5% |
| 31 Maret 2026 | $2.07 | $1.21 | 71.5% | |
| 31 Des. 2025 | $-1.24 | $-0.91 | -37.0% | |
| 30 Sep. 2025 | $-0.53 | $-0.57 | 6.6% | |
| 30 Juni 2025 | $-0.89 | $-0.47 | -88.5% | |
| 31 Maret 2025 | $0.92 | $0.81 | 13.8% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $463M | |
| SG&A Expense | $2.05B | $1.76B | $1.43B | $1.26B | $265M | $167M | |
| Operating Income | $-396M | $57M | $-236M | $-590M | $-544M | $-402M | |
| Interest Expense | · | · | $25M | $23M | $5M | $4M | |
| Other Non-op | $-23M | $-105.0K | $-7M | $2M | $-1M | · | |
| Pretax Income | $-437M | $33M | $-267M | $-610M | $-571M | $-406M | |
| Income Tax | $6M | $7M | $3M | $-523.0K | $846.0K | $1M | |
| Net Income | $-443M | $25M | $-271M | $-606M | $-573M | $-407M | |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| Shares (Basic) | 262,388,000 | 240,386,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| Shares (Diluted) | 262,388,000 | 265,853,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| EBITDA | $-367M | $89M | $-205M | · | $-530M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826M | |
| Short-term Investments | · | $624M | $690M | · | · | · | |
| Receivables | $363M | · | · | · | · | · | |
| Other Current Assets | $24M | $21M | $7M | $6M | $4M | · | |
| Current Assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | |
| PP&E (Net) | $88M | $67M | $62M | $60M | $47M | $36M | |
| PP&E (Gross) | $230M | $181M | $150M | $117M | $89M | $63M | |
| Accum. Depreciation | $142M | $114M | $88M | $57M | $42M | $27M | |
| Other Non-current Assets | $120M | $82M | $83M | $95M | $97M | $13M | |
| Total Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | |
| Accounts Payable | $507M | $432M | $273M | $298M | $235M | $138M | |
| Current Liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | |
| Capital Leases | $52M | $61M | $67M | $72M | $77M | · | |
| Other Non-current Liabilities | $52M | $61M | $68M | $72M | $77M | $0 | |
| Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | |
| Total Debt | $430M | $300M | $299M | · | $0 | · | |
| Common Stock | · | · | · | · | · | $2.0K | |
| Paid-in Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133M | |
| Retained Earnings | $-3.29B | $-2.85B | $-2.88B | $-2.61B | $-2.00B | $-1.43B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | |
| AOCI | $18M | $-2M | $1M | $-10M | $-4M | $879.0K | |
| Stockholders' Equity | $978M | $1.01B | $804M | $890M | $1.39B | $-1.30B | |
| Liabilities + Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $29M | $32M | $31M | $15M | $15M | $11M | |
| Stock-based Comp | $88M | $110M | $160M | $112M | $86M | $36M | |
| Deferred Tax | $2M | $-2M | $58.0K | $-165.0K | $-101.0K | $-67.0K | |
| Other Non-cash | $1.42B | $813M | $-192M | · | $290M | · | |
| Operating Cash Flow | $1.09B | $978M | $-272M | $380M | $-182M | $223M | |
| CapEx | $36M | $28M | $26M | $29M | $26M | $14M | |
| Investing Cash Flow | $-241M | $-1.39B | $577M | $-227M | $-775M | $-345M | |
| Debt Issued | $410M | $0 | $0 | $305M | $0 | $147M | |
| Net Debt Issued | $410M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $399M | $68M | $6M | $301M | $1.24B | $612M | |
| Net Change in Cash | $1.25B | $-341M | $311M | $455M | $282M | $490M | |
| Taxes Paid | $18M | $674.0K | $2M | $2M | $697.0K | $2M | |
| Free Cash Flow | $1.06B | $950M | $-298M | · | $-208M | · | |
| Levered FCF | · | · | $-323M | · | $-212M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4% | 0.62% | -4.0% | · | -29.6% | · | |
| Net Margin | -3.8% | 0.28% | -4.6% | · | -31.1% | · | |
| Pretax Margin | -3.7% | 0.36% | -4.6% | · | -31.0% | · | |
| EBITDA Margin | -3.1% | 0.97% | -3.5% | · | -28.8% | · | |
| ROA | -7.9% | 0.60% | -6.7% | · | -20.5% | · | |
| ROE | -44.5% | 2.8% | -32.0% | · | -36.7% | · | |
| ROIC | -28.5% | 3.4% | -21.6% | · | -39.3% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | 1.3 | · | 1.2 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | · | 0.6 | · | |
| Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| LT Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| Interest Coverage | · | · | -9.6 | · | -115.4 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.1 | 2.2 | 1.4 | · | 0.7 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $44.60 | $34.52 | $26.45 | · | $10.27 | · | |
| Cash Flow / Share | $4.17 | $3.68 | $-1.23 | · | $-1.02 | · | |
| EPS (TTM) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.5% | 56.5% | 47.9% | 115.6% | 297.3% | · | |
| Revenue CAGR 3Y | 43.5% | 70.9% | 133.1% | · | · | · | |
| Revenue CAGR 5Y | 90.8% | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | · | |
| Net Income TTM | $-443M | $25M | $-271M | $-606M | $-573M | · | |
| P/E | -8.5 | 134.4 | -7.5 | -0.9 | -2.5 | · | |
| Earnings Yield | -11.8% | 0.74% | -13.3% | -115.9% | -40.8% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B | $1.52B | $1.47B | $995M | $978M | |
| SG&A Expense | $691M | $706M | $511M | $522M | $534M | $483M | $466M | $460M | $435M | $394M | $364M | $326M | $337M | $399M | $1.02B | $79M | |
| Operating Income | $389M | $704M | $-334M | $-129M | $-230M | $297M | $-148M | $-48M | $68M | $186M | $-145M | $-58M | $-7M | $-25M | $-222M | $-192M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | |
| Other Non-op | $-915.0K | $71.0K | $-20M | $-3M | $3M | $-3M | $68.0K | $2M | $-872.0K | $-1M | $1M | $-414.0K | $-2M | $-6M | $1M | $3M | |
| Pretax Income | $383M | $699M | $-353M | $-139M | $-234M | $288M | $-154M | $-52M | $61M | $178M | $-151M | $-65M | $-14M | $-38M | $-227M | $-195M | |
| Income Tax | $21M | $20M | $-247.0K | $-2M | $-5M | $13M | $-404.0K | $2M | $5M | $996.0K | $-806.0K | $915.0K | $1M | $2M | $-715.0K | $-2M | |
| Net Income | $362M | $679M | $-353M | $-137M | $-228M | $275M | $-154M | $-55M | $56M | $177M | $-150M | $-65M | $-16M | $-40M | $-226M | $-193M | |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 | $0.24 | $0.77 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 | $0.20 | $0.62 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| Shares (Basic) | 302,220,000 | 298,184,000 | · | 259,273,000 | 255,531,000 | 251,279,000 | · | 243,106,000 | 238,672,000 | 231,443,000 | · | 223,099,000 | 219,400,000 | 216,913,000 | · | 212,822,733 | |
| Shares (Diluted) | 333,432,000 | 329,751,000 | · | 259,273,000 | 255,531,000 | 305,938,000 | · | 243,106,000 | 303,965,000 | 293,796,000 | · | 223,099,000 | 219,400,000 | 216,913,000 | · | 212,822,733 | |
| EBITDA | $389M | $711M | · | $-129M | $-230M | $304M | · | $-48M | $68M | $193M | · | $-58M | $-7M | $-20M | · | $-192M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B | $2.32B | $2.11B | $1.56B | $2.11B | |
| Receivables | $380M | $587M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $60M | $26M | $24M | $29M | $30M | $23M | $21M | $21M | $16M | $9M | · | $8M | $8M | $11M | · | $16M | |
| Current Assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $3.36B | $3.50B | · | $2.99B | $4.19B | $4.13B | · | $3.93B | |
| PP&E (Net) | $101M | $94M | $88M | $83M | $78M | $72M | $67M | $67M | $64M | $61M | · | $62M | $63M | $64M | · | $56M | |
| PP&E (Gross) | · | · | $230M | · | · | · | $181M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $142M | · | · | · | $114M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $122M | $123M | $120M | $121M | $116M | $94M | $82M | $84M | $87M | $87M | · | $89M | $92M | $95M | · | $97M | |
| Total Assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B | |
| Accounts Payable | $526M | $506M | $650M | $557M | $584M | $634M | $432M | $395M | $348M | $303M | · | $260M | $262M | $299M | · | $252M | |
| Current Liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B | $3.50B | $3.02B | · | $2.06B | $3.24B | $3.18B | · | $2.85B | |
| Capital Leases | · | · | $52M | · | · | · | $61M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $50M | $51M | $52M | $56M | $57M | $59M | $61M | $64M | $65M | $66M | · | $69M | $70M | $71M | · | $74M | |
| Total Liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | · | $2.43B | $3.61B | $3.55B | · | $3.22B | |
| Total Debt | $432M | $431M | · | $686M | $300M | $300M | · | $299M | $299M | $299M | · | $299M | $298M | $298M | · | $298M | |
| Paid-in Capital | $4.32B | $4.28B | $4.26B | $3.95B | $3.95B | $3.90B | $3.87B | $3.84B | $3.79B | $3.74B | · | $3.65B | $3.62B | $3.58B | · | $3.48B | |
| Retained Earnings | $-2.25B | $-2.62B | $-3.29B | $-2.94B | $-2.80B | $-2.58B | $-2.85B | $-2.70B | $-2.64B | $-2.70B | · | $-2.73B | $-2.66B | $-2.65B | · | $-2.38B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| AOCI | $-8M | $5M | $18M | $16M | $14M | $10M | $-2M | $26M | $-3M | $-3M | · | $-4M | $-7M | $-4M | · | $-14M | |
| Stockholders' Equity | $2.05B | $1.66B | $978M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | · | $919M | $950M | $930M | · | $1.08B | |
| Liabilities + Equity | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | $8M | $8M | $9M | $9M | $5M | $4M | $4M | |
| Stock-based Comp | $21M | $16M | $18M | $20M | $24M | $25M | $26M | $29M | $29M | $26M | $26M | $29M | $33M | $71M | $29M | $29M | |
| Deferred Tax | $-2M | $-6M | $3M | $-175.0K | $-36.0K | $36.0K | $-2M | $-119.0K | $130.0K | $-79.0K | $-37.0K | $69.0K | $209.0K | $-183.0K | $-171.0K | $2.0K | |
| Other Non-cash | · | $1.92B | · | · | · | $572M | · | · | · | $423M | · | · | · | $378M | · | · | |
| Operating Cash Flow | $2.09B | $2.62B | $672M | $-965M | $509M | $879M | $347M | $-500M | $497M | $634M | $297M | $-1.15B | $166M | $415M | $151M | $-548M | |
| CapEx | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $7M | $10M | |
| Investing Cash Flow | $-2.83B | $-590M | $-49M | $150M | $-168M | $-174M | $-31M | $-578M | $-478M | $-301M | $172M | $225M | $44M | $136M | $-707M | $299M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $-4M | $8M | $364M | $22M | $5M | $4M | $19M | $19M | $27M | $1M | $2M | $3M | $506.0K | $527.0K | $423.0K | |
| Net Change in Cash | $-729M | $2.03B | $631M | $-451M | $363M | $709M | $319M | $-1.06B | $38M | $361M | $470M | $-922M | $212M | $551M | $-555M | $-249M | |
| Taxes Paid | $1M | $44.0K | $19.0K | $2M | $15M | $0 | $38.0K | $552.0K | · | · | $1M | $600.0K | · | · | $233.0K | $555.0K | |
| Free Cash Flow | · | $2.61B | · | · | · | $870M | · | · | · | $628M | · | · | · | $407M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $623M | · | · | · | $401M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.0% | 15.2% | · | -4.3% | -8.1% | 9.8% | · | -2.0% | 3.1% | 8.7% | · | -4.0% | -0.43% | -1.7% | · | -19.7% | |
| Net Margin | 7.4% | 14.6% | · | -4.6% | -8.0% | 9.0% | · | -2.2% | 2.5% | 8.3% | · | -4.5% | -1.0% | -2.7% | · | -19.7% | |
| Pretax Margin | 7.8% | 15.0% | · | -4.7% | -8.2% | 9.5% | · | -2.2% | 2.8% | 8.3% | · | -4.5% | -0.94% | -2.6% | · | -20.0% | |
| EBITDA Margin | 8.0% | 15.3% | · | -4.3% | -8.1% | 10.0% | · | -2.0% | 3.1% | 9.0% | · | -4.0% | -0.43% | -1.4% | · | -19.7% | |
| ROA | 4.1% | 9.0% | · | -2.7% | -4.0% | 5.4% | · | -1.4% | 1.2% | 4.0% | · | -1.7% | -0.33% | -0.90% | · | -5.2% | |
| ROE | 22.5% | 45.3% | · | -12.6% | -19.9% | 23.3% | · | -5.2% | 5.4% | 18.1% | · | -6.5% | -1.4% | -3.5% | · | -14.6% | |
| ROIC | 14.8% | 32.7% | · | -7.5% | -15.5% | 17.4% | · | -3.4% | 4.4% | 13.9% | · | -4.9% | -0.57% | -2.2% | · | -13.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.0 | 1.2 | · | 1.5 | 1.3 | 1.3 | · | 1.4 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 31.4 | · | -9.5 | -1.1 | -4.1 | · | -31.4 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 25.7 | 15.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $14.64 | $14.09 | · | $11.52 | $11.21 | $9.96 | · | $9.97 | $7.30 | $7.29 | · | $6.45 | $6.93 | $6.78 | · | $4.60 | |
| Cash Flow / Share | · | $7.94 | · | · | · | $2.87 | · | · | · | $2.16 | · | · | · | $1.91 | · | · | |
| EPS (TTM) | $1.45 | $-0.54 | · | $-1.00 | $-0.69 | $0.40 | · | $-0.08 | $-0.15 | $-0.42 | · | $-1.59 | $-2.21 | $-2.67 | · | $-2.63 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.32B | $13.30B | · | $11.29B | $10.73B | $10.08B | · | $8.22B | $7.23B | $6.54B | · | $5.43B | $4.96B | $4.46B | · | $3.46B | |
| Net Income TTM | $551M | $-39M | · | $-244M | $-161M | $123M | · | $29M | $18M | $-54M | · | $-347M | $-474M | $-571M | · | $-579M | |
| P/E | 19.7 | -21.2 | · | -18.9 | -31.1 | 32.8 | · | -265.1 | -105.5 | -35.4 | · | -3.5 | -3.6 | -2.4 | · | -1.9 | |
| Earnings Yield | 5.1% | -4.7% | · | -5.3% | -3.2% | 3.0% | · | -0.38% | -0.95% | -2.8% | · | -28.5% | -27.4% | -40.8% | · | -52.7% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| Margin Operasi % | -3.4% | 0.62% | -4.0% | · | -29.6% |
| Laba Bersih | $-443M | $25M | $-271M | $-606M | $-573M |
| EPS Dilusian | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.4 | 0.3 | 0.4 | · | 0.0 |
| Rasio Lancar | 0.9 | 0.8 | 1.3 | · | 1.2 |
| Rasio Cepat | 0.6 | 0.6 | 0.8 | · | 0.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $1.06B | $950M | $-298M | · | $-208M |
Pemilik institusional (13F) 459 pengaju · $6.2B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 125 (+51 vs Kuartal sebelumnya) | 46 (-18 vs Kuartal sebelumnya) | 147 (+22 vs Kuartal sebelumnya) | 115 (+3 vs Kuartal sebelumnya) | +22.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BlackRock, Inc. | $587.153.449 | 20.587.428 | 9,50% | Saham |
| D. E. Shaw & Co., Inc. | $360.595.957 | 12.643.617 | 5,84% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $314.559.172 | 11.029.424 | 5,09% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $301.725.543 | 10.579.437 | 4,88% | Saham |
| VANGUARD GROUP INC | $297.476.962 | 20.701.250 | 4,82% | Saham |
| AMERICAN CENTURY COMPANIES INC | $258.255.502 | 9.055.242 | 4,18% | Saham |
| JANE STREET GROUP, LLC | $181.530.912 | 6.365.039 | 2,94% | Saham |
| Thrive Capital Management, LLC | $180.919.957 | 6.343.617 | 2,93% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $165.994.311 | 5.819.186 | 2,69% | Saham |
| STATE STREET CORP | $165.454.531 | 5.801.351 | 2,68% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $162.917.648 | 5.712.400 | 2,64% | Opsi beli |
| FMR LLC | $142.557.861 | 4.998.523 | 2,31% | Saham |
| CITADEL ADVISORS LLC | $120.626.823 | 4.229.552 | 1,95% | Saham |
| TWO SIGMA INVESTMENTS, LP | $115.097.850 | 4.035.689 | 1,86% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $101.885.043 | 3.571.731 | 1,65% | Saham |
| BIT Capital GmbH | $97.480.134 | 3.417.957 | 1,58% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $93.673.940 | 3.284.500 | 1,52% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $86.282.012 | 3.025.316 | 1,40% | Saham |
| GLYNN CAPITAL MANAGEMENT LLC | $73.462.615 | 2.575.828 | 1,19% | Saham |
| CITADEL ADVISORS LLC | $72.469.320 | 2.541.000 | 1,17% | Opsi beli |
| GOLDMAN SACHS GROUP INC | $65.298.165 | 2.289.557 | 1,06% | Saham |
| NORTHERN TRUST CORP | $63.063.680 | 2.211.209 | 1,02% | Saham |
| WOLVERINE ASSET MANAGEMENT LLC | $61.825.656 | 2.167.800 | 1,00% | Opsi jual |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.458.493 | 2.119.863 | 0,98% | Saham |
| MORGAN STANLEY | $60.299.272 | 2.114.280 | 0,98% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55.351.616 | 1.940.800 | 0,90% | Opsi jual |
| JANE STREET GROUP, LLC | $53.968.396 | 1.892.300 | 0,87% | Opsi beli |
| Nuveen, LLC | $50.501.648 | 1.770.745 | 0,82% | Saham |
| BlackBarn Capital Partners LP | $49.910.000 | 1.750.000 | 0,81% | Opsi jual |
| BNP PARIBAS FINANCIAL MARKETS | $48.660.710 | 1.706.196 | 0,79% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $45.996.029 | 1.612.764 | 0,74% | Saham |
| CITADEL ADVISORS LLC | $44.459.828 | 1.558.900 | 0,72% | Opsi jual |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $41.354.000 | 1.450.000 | 0,67% | Saham |
| BANK OF AMERICA CORP /DE/ | $37.594.294 | 1.318.173 | 0,61% | Saham |
| Assenagon Asset Management S.A. | $35.592.732 | 1.247.992 | 0,58% | Saham |
| TWO SIGMA ADVISERS, LP | $35.534.136 | 2.472.800 | 0,58% | Saham |
| UBS Group AG | $34.596.357 | 1.213.056 | 0,56% | Saham |
| JANE STREET GROUP, LLC | $33.796.200 | 1.185.000 | 0,55% | Opsi jual |
| GROUP ONE TRADING LLC | $32.744.154 | 1.148.112 | 0,53% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $31.200.652 | 1.093.992 | 0,51% | Saham |
| Qube Research & Technologies Ltd | $30.913.940 | 1.083.939 | 0,50% | Saham |
| TUDOR INVESTMENT CORP ET AL | $29.055.948 | 1.018.792 | 0,47% | Saham |
| GILDER GAGNON HOWE & CO LLC | $28.576.515 | 1.001.982 | 0,46% | Saham |
| JPMORGAN CHASE & CO | $26.387.407 | 885.558 | 0,43% | Saham |
| FEDERATED HERMES, INC. | $26.096.200 | 915.014 | 0,42% | Saham |
| WELLS FARGO & COMPANY/MN | $23.408.907 | 820.789 | 0,38% | Saham |
| Walleye Capital LLC | $23.243.058 | 814.974 | 0,38% | Saham |
| Point72 Asset Management, L.P. | $22.809.212 | 799.762 | 0,37% | Saham |
| Walleye Trading LLC | $22.744.700 | 797.500 | 0,37% | Opsi beli |
| Bank of New York Mellon Corp | $22.032.138 | 772.515 | 0,36% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC | 18 Sep. 2026 | 12,10% | Amandemen | · | SEC |
| Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 pengajuan | 13 Nov. 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 23 orang dalam · 12 pejabat · 12 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer | 30 Juni 2026 S | 7.751.570 | 1 | 8 | $-58.759.399 |
| Richard Scott Blackley | Chief Financial Officer | 3 Sep. 2026 S | 1.046.108 | 0 | 9 | $-7.941.907 |
| Janet Liang | President, Oscar Insurance | 3 Sep. 2026 S | 248.697 | 0 | 5 | $-821.072 |
| Steven Wolin | Chief Operating Officer | 1 Des. 2024 M | 102.598 | 0 | 0 | $0 |
| Meghan V. Joyce | Chief Operating Officer | 1 Maret 2022 M | 43.070 | 0 | 0 | $0 |
| Joshua Kushner | Co-Founder and Vice Chairman | 18 Sep. 2026 J | 0 | 0 | 0 | $0 |
| Victoria Baltrus | Chief Accounting Officer | 3 Sep. 2026 S | 213.631 | 0 | 5 | $-194.480 |
| Adam Mcananey | Chief Legal Officer | 3 Sep. 2026 S | 209.004 | 0 | 5 | $-783.513 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 5 Des. 2024 M | 430.216 | 0 | 0 | $0 |
| Ranmali Bopitiya | EVP & Chief Legal Officer | 1 Des. 2024 M | 241.488 | 0 | 0 | $0 |
| Dennis Weaver | Chief Clinical Officer | 1 Des. 2022 M | 27.110 | 0 | 0 | $0 |
| Joel Klein | Chief Policy & Strat. Officer | 18 Agu 2021 M | 17 | 0 | 0 | $0 |
| Vanessa Ames Wittman | Direktur | 18 Sep. 2026 S | 112.121 | 0 | 1 | $-806.000 |
| Mario Schlosser | Direktur | 3 Sep. 2026 S | 449.444 | 0 | 29 | $-68.790.950 |
| William Gassen | Direktur | 9 Juli 2026 A | 82.840 | 0 | 0 | $0 |
| David Plouffe | Direktur | 9 Juli 2026 A | 137.121 | 0 | 0 | $0 |
| Sid Sankaran | Direktur | 9 Juli 2026 A | 22.609 | 0 | 0 | $0 |
| Laura W Lang | Direktur | 4 Juni 2026 A | 82.840 | 0 | 0 | $0 |
| Jeffery H Boyd | Direktur | 9 April 2026 A | 705.673 | 0 | 0 | $0 |
| Elbert O. Robinson Jr. | Direktur | 12 Mei 2025 S | 64.512 | 0 | 0 | $0 |
| Jr Charles E Phillips | Direktur | 14 Okt. 2022 A | 85.787 | 0 | 0 | $0 |
| Teri List-Stoll | Direktur | 5 Maret 2021 A | 50.000 | 0 | 0 | $0 |
| Ari Fischel | · | 5 Maret 2021 A | 0 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 46 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| ABLS · Abacus FCF ETF Trust | 5,83% | 867 NS | 31 Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,95% | 188.213 SH | 2 Okt. 2026 | Harian |
| RNIN · EA Series Trust | 1,20% | 70.047 NS | 31 Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,74% | 307.696 NS | 31 Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,60% | 69.666 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,52% | 2.269.828 SH | 11 Sep. 2026 | Harian |
| JSMD · Janus Detroit Street Trust | 0,51% | 171.181 NS | 31 Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,40% | 258.034 SH | 19 Agu 2026 | Harian |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 48.469 SH | 2 Okt. 2026 | Harian |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,35% | 152.933 NS | 31 Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,31% | 8.798 NS | 31 Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 61.099 NS | 31 Juli 2026 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0,27% | 19.102 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,26% | 6.175.602 SH | 11 Sep. 2026 | Harian |
| FBUF · Fidelity Greenwood Street Trust | 0,25% | 1.889 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,24% | 71.367 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,24% | 115.406 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,21% | 1.387.125 SH | 19 Agu 2026 | Harian |
| FHEQ · Fidelity Greenwood Street Trust | 0,21% | 61.010 NS | 31 Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,19% | 3.171.535 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,16% | 805.292 NS | 31 Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,16% | 145.781 SH | 2 Okt. 2026 | Harian |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 27.872 NS | 31 Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,11% | 96.895 SH | 11 Sep. 2026 | Harian |
| FNCL · FIDELITY COVINGTON TRUST | 0,08% | 61.975 NS | 31 Juli 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,08% | 5.488.922 SH | 19 Agu 2026 | Harian |
| VFH · VANGUARD WORLD FUND | 0,08% | 384.466 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,07% | 14.630 SH | 11 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 2.534.194 SH | 19 Agu 2026 | Harian |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 12.495 SH | 2 Okt. 2026 | Harian |
| DFSU · Dimensional ETF Trust | 0,03% | 20.892 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 21.472 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 286.808 NS | 31 Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 12.166 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 50.403 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 64.590 SH | 11 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 7.601.113 SH | 19 Agu 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 194.738 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19.808 SH | 19 Agu 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,01% | 66.708 NS | 31 Juli 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 53.203 SH | 19 Agu 2026 | Harian |
| ITOT · iShares Trust | 0,01% | 287.602 SH | 11 Sep. 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 472 NS | 31 Juli 2026 | N-PORT |
| IAK · iShares Trust | · | 117.671 SH | 11 Sep. 2026 | Harian |
| ISCB · iShares Trust | · | 10.063 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 286.871 SH | 11 Sep. 2026 | Harian |
OSCR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
Target Harga 12 Bulan
10 analis · 2026-10-03Target rata-rata $35.40 +14,4%
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| OSCR | · | -8.5 | 27.5% | -3.8% | -44.5% | · |
| AFL | $57.20B | 16.2 | -9.3% | 21.2% | 12.9% | · |
| PRU | · | · | · | · | · | · |
| PFG | $19.18B | 16.8 | -3.1% | 7.6% | 10.3% | · |
| UNM | · | · | · | · | · | · |
| GL | $12.90B | 9.9 | 3.7% | 19.4% | 20.4% | · |
| PRI | $8.22B | 11.3 | 6.6% | 22.8% | 31.9% | · |
| LNC | $8.46B | 7.6 | -1.2% | 6.5% | 12.3% | · |
| CNO | $4.01B | 18.5 | 0.85% | 5.1% | 8.9% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.